(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three biggest winners today are Brookfield, DouYu, and Bionano Genomics.

The three biggest losers today are SmileDirectClub, Royal Caribbean Cruises, and AMC.

Premarket Winners today

1. Brookfield (BAM) – Premarket: 4.85%

Brookfield Asset Management Ltd. provides alternative asset management services. Its renewable power and transition business includes the ownership, operation, and development of hydroelectric, wind, solar, and energy transition power generating assets. The company's infrastructure business engages in the ownership, operation, and development of utilities, transport, midstream, data and sustainable resource assets. In addition, its private equity business offers business, infrastructure, and industrials services; and real estate business, which includes core investments, and transitional and development investments. Further, the company engages in the residential development business including homebuilding, and condominium and land development. The company was incorporated in 2022 and is headquartered in Toronto, Canada.

NYSE ended the session with Brookfield sliding 1.51% to $31.95 on Friday, after five consecutive sessions in a row of losses. NYSE dropped 0.36% to $15,600.70, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, Brookfield has a trailing twelve months EPS of $5.22.

PE Ratio

Brookfield has a trailing twelve months price to earnings ratio of 6.12. Meaning, the purchaser of the share is investing $6.12 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.57%.

Yearly Top and Bottom Value

Brookfield’s stock is valued at $31.95 at 08:34 EST, way below its 52-week high of $36.50 and way above its 52-week low of $26.76.

Moving Average

Brookfield’s value is below its 50-day moving average of $32.05 and above its 200-day moving average of $31.93.

More news about Brookfield.

2. DouYu (DOYU) – Premarket: 0.98%

DouYu International Holdings Limited, together with its subsidiaries, operates a platform on PC and mobile apps that provides interactive games and entertainment live streaming services in the People's Republic of China. Its platform connects game developers and publishers, professional eSports teams or players and eSports tournament organizers, advertisers, and viewers. The company also sponsors professional players and teams, and organizes eSports tournaments. In addition, it streams other content to include a spectrum of live streaming entertainment options, such as talent shows, music, outdoor, and travel. Further, the company records and offers video clips to allow users to watch replays of selective live streaming content. DouYu International Holdings Limited was founded in 2014 and is headquartered in Wuhan, the People's Republic of China.

NASDAQ ended the session with DouYu falling 0.49% to $1.02 on Friday, after four sequential sessions in a row of losses. NASDAQ rose 0.95% to $13,630.61, following the last session’s upward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, DouYu has a trailing twelve months EPS of $0.01.

PE Ratio

DouYu has a trailing twelve months price to earnings ratio of 101.5. Meaning, the purchaser of the share is investing $101.5 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.17%.

Yearly Top and Bottom Value

DouYu’s stock is valued at $1.02 at 08:34 EST, way below its 52-week high of $2.12 and way higher than its 52-week low of $0.90.

Volume

Today’s last reported volume for DouYu is 121688 which is 81.28% below its average volume of 650372.

More news about DouYu.

3. Bionano Genomics (BNGO) – Premarket: 0.63%

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.

NASDAQ ended the session with Bionano Genomics dropping 3.02% to $0.64 on Friday while NASDAQ jumped 0.95% to $13,630.61.

Earnings Per Share

As for profitability, Bionano Genomics has a trailing twelve months EPS of $-0.45.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -51.51%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Bionano Genomics’s EBITDA is 4.81.

Yearly Top and Bottom Value

Bionano Genomics’s stock is valued at $0.64 at 08:34 EST, way below its 52-week high of $4.35 and higher than its 52-week low of $0.60.

Moving Average

Bionano Genomics’s value is way below its 50-day moving average of $0.79 and way below its 200-day moving average of $1.61.

Volume

Today’s last reported volume for Bionano Genomics is 2748490 which is 67.83% below its average volume of 8545980.

More news about Bionano Genomics.

4. GoPro (GPRO) – Premarket: 0.47%

GoPro, Inc. develops and sells cameras, mountable and wearable accessories, and subscription services and software in the Americas, Europe, the Middle East, Africa, the Asia and Pacific region, and internationally. The company provides cloud connected HERO11 Black, HERO11 Black Mini, HERO10 Black, HERO10 Black Bones, HERO9 Black, and HERO8 Black waterproof cameras; MAX, a 360-degree waterproof camera; GoPro, a subscription service that includes full access to the Quik app, cloud storage supporting source video and photo quality, camera replacement, and damage protection; Quik subscription offers access to editing tools, which allows users to edit photos, videos, and create cinematic stories; and Quik app, a mobile app that enable users to get their favorite photos and videos with footage from any phone or camera. It also offers mounts and accessories comprising equipment-based mounts consisting of helmet, handlebar, roll bar, and tripod mounts that enable consumers to wear the mount on their bodies, such as wrist housings, magnetic swivel clips, chest harnesses, and head straps; media, display, and light mods; spare batteries, dive filters, and charging accessories and cables; and lifestyle gears. In addition, the company provides mobile and web applications that provides media workflow for archiving, editing, multi-clip story creation, and sharing content on the fly. GoPro, Inc. markets and sells its products through retailers and wholesale distributors, as well as through its GoPro.com website. The company was formerly known as Woodman Labs, Inc. and changed its name to GoPro, Inc. in February 2014. GoPro, Inc. was founded in 2002 and is headquartered in San Mateo, California.

NASDAQ ended the session with GoPro falling 1.67% to $4.12 on Friday while NASDAQ rose 0.95% to $13,630.61.

Earnings Per Share

As for profitability, GoPro has a trailing twelve months EPS of $-0.05.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.14%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 162.5% and a negative 21.1%, respectively.

Moving Average

GoPro’s worth is under its 50-day moving average of $4.28 and way under its 200-day moving average of $5.08.

More news about GoPro.

5. iShares Short-Term (IGSB) – Premarket: 0.08%

NASDAQ ended the session with iShares Short-Term dropping 0.11% to $50.10 on Friday while NASDAQ rose 0.95% to $13,630.61.

Earnings Per Share

As for profitability, iShares Short-Term has a trailing twelve months EPS of $2.48.

Volume

Today’s last reported volume for iShares Short-Term is 543705 which is 86.21% below its average volume of 3944390.

More news about iShares Short-Term.

6. Aware, Inc. (AWRE) – Premarket: 0%

Aware, Inc., a authentication company, provides biometrics software products and solutions for government agencies and commercial entities in the United States, Brazil, the United Kingdom, and internationally. The company offers biometric software solution, which includes Knomi, a mobile biometric framework which provides multiple biometric modality options; AwareABIS, an automated biometric identification system used for large-scale biometric identification and deduplication; AFIX suite used for small-scale law enforcement focused biometric identification; and AFIX Tracker for fingerprint, palmprint, and latent print identification. It also provides BioSP, a service-oriented platform enables biometric system with advanced biometric data processing and management in a web services architecture; WebEnroll, a browser-based biometric enrollment and data management solution; and AwareID, an adaptive authentication platform provides biometric face and voice analysis, and document validation for cloud-based biometric application programming interfaces and turnkey services. In addition, the company offers biometrics applications, such as Nexa line, a biometric search and match SDKs including Nexa Fingerprint, Nexa Face, Nexa Iris, and Nexa Voice; and AwareXM, an interoperable fingerprint matching SDK that provides fingerprint minutiae extraction, template generation, and fingerprint authentication. Further, it sells imaging products used in medical and advanced imaging application; offers program management and software engineering services, and software maintenance services. The company sells its products, services, and solutions through systems integrators, direct, and original equipment manufacturers and value added resellers channel Aware, Inc. was incorporated in 1986 and is headquartered in Burlington, Massachusetts.

NASDAQ ended the session with Aware, Inc. dropping 1.2% to $1.65 on Friday, following the last session’s downward trend. NASDAQ rose 0.95% to $13,630.61, following the last session’s upward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Aware, Inc. has a trailing twelve months EPS of $-0.09.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.07%.

More news about Aware, Inc..

7. Fox Corporation (FOX) – Premarket: 0%

Fox Corporation operates as a news, sports, and entertainment company in the United States (U.S.). The company operates through Cable Network Programming; Television; and Other, Corporate and Eliminations segments. The Cable Network Programming segment produces and licenses news, business news, and sports content for distribution through traditional and virtual multi-channel video programming distributors (MVPDs) and other digital platforms, primarily in the U.S. It operates FOX News, a national cable news channel; FOX Business, a business news national cable channel; FS1 and FS2 multi-sport national networks; FOX Sports Racing, a video programming service that comprises motor sports programming; FOX Soccer Plus, a video programming network for live soccer and rugby competitions; FOX Deportes, a Spanish-language sports programming service; and Big Ten Network, a national video programming service. The Television segment acquires, produces, markets, and distributes programming. It operates The FOX Network, a national television broadcast network that broadcasts sports programming and entertainment; Tubi, an advertising-supported video-on-demand service; Fox Alternative Entertainment, a full-service production studio that develops and produces unscripted and alternative programming; MyNetworkTV, a programming distribution service; and Blockchain Creative Labs, which is focuses on the creation, distribution and monetization of Web3 content. This segment owns and operates 29 broadcast television stations. The Other, Corporate and Eliminations segment owns the FOX Studios Lot that provides production and post-production services, including 15 sound stages, two broadcast studios, theaters and screening rooms, editing rooms, and other television and film production facilities in Los Angeles, California. The company was incorporated in 2018 and is based in New York, New York.

NASDAQ ended the session with Fox Corporation falling 0.68% to $30.82 on Friday, after four sequential sessions in a row of losses. NASDAQ jumped 0.95% to $13,630.61, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Fox Corporation has a trailing twelve months EPS of $2.14.

PE Ratio

Fox Corporation has a trailing twelve months price to earnings ratio of 14.4. Meaning, the purchaser of the share is investing $14.4 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.91%.

Volatility

Fox Corporation’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.73%, a positive 0.31%, and a positive 1.08%.

Fox Corporation’s highest amplitude of average volatility was 0.73% (last week), 0.83% (last month), and 1.08% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 18.2%, now sitting on 14.91B for the twelve trailing months.

Sales Growth

Fox Corporation’s sales growth is 5.7% for the present quarter and 5.5% for the next.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Fox Corporation’s EBITDA is 1.38.

More news about Fox Corporation.

8. Fox Corporation (FOXA) – Premarket: 0%

Fox Corporation operates as a news, sports, and entertainment company in the United States (U.S.). The company operates through Cable Network Programming; Television; and Other, Corporate and Eliminations segments. The Cable Network Programming segment produces and licenses news, business news, and sports content for distribution through traditional and virtual multi-channel video programming distributors (MVPDs) and other digital platforms, primarily in the U.S. It operates FOX News, a national cable news channel; FOX Business, a business news national cable channel; FS1 and FS2 multi-sport national networks; FOX Sports Racing, a video programming service that comprises motor sports programming; FOX Soccer Plus, a video programming network for live soccer and rugby competitions; FOX Deportes, a Spanish-language sports programming service; and Big Ten Network, a national video programming service. The Television segment acquires, produces, markets, and distributes programming. It operates The FOX Network, a national television broadcast network that broadcasts sports programming and entertainment; Tubi, an advertising-supported video-on-demand service; Fox Alternative Entertainment, a full-service production studio that develops and produces unscripted and alternative programming; MyNetworkTV, a programming distribution service; and Blockchain Creative Labs, which is focuses on the creation, distribution and monetization of Web3 content. This segment owns and operates 29 broadcast television stations. The Other, Corporate and Eliminations segment owns the FOX Studios Lot that provides production and post-production services, including 15 sound stages, two broadcast studios, theaters and screening rooms, editing rooms, and other television and film production facilities in Los Angeles, California. The company was incorporated in 2018 and is based in New York, New York.

NASDAQ ended the session with Fox Corporation falling 0.87% to $32.90 on Friday, after four sequential sessions in a row of losses. NASDAQ jumped 0.95% to $13,630.61, following the last session’s upward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, Fox Corporation has a trailing twelve months EPS of $2.14.

PE Ratio

Fox Corporation has a trailing twelve months price to earnings ratio of 15.37. Meaning, the purchaser of the share is investing $15.37 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.91%.

More news about Fox Corporation.

9. Merrimack Pharmaceuticals (MACK) – Premarket: 0%

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

NASDAQ ended the session with Merrimack Pharmaceuticals jumping 0.32% to $12.40 on Friday, following the last session’s upward trend. NASDAQ rose 0.95% to $13,630.61, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Merrimack Pharmaceuticals has a trailing twelve months EPS of $-0.12.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.12%.

More news about Merrimack Pharmaceuticals.

10. Inovio Pharmaceuticals (INO) – Premarket: -0.07%

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia, including cervical, vulvar, and anal dysplasia and is under phase II/III clinical trials; INO-3107 for HPV-related recurrent respiratory rapillomatosis and is under Phase 1/2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under phase 1b trial; and INO-4500 vaccine for lassa fever, which is under phase 1b trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

NASDAQ ended the session with Inovio Pharmaceuticals falling 5.59% to $0.45 on Friday, after two successive sessions in a row of losses. NASDAQ jumped 0.95% to $13,630.61, following the last session’s upward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Inovio Pharmaceuticals has a trailing twelve months EPS of $-0.94.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -87.1%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Inovio Pharmaceuticals’s EBITDA is -6.34.

More news about Inovio Pharmaceuticals.

Premarket Losers Today

1. SmileDirectClub (SDC) – Premarket: -1.45%

SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a customer's dentist or orthodontist, and facilitating remote clinical monitoring through a network of orthodontists and general dentists through its proprietary teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.

NASDAQ ended the session with SmileDirectClub falling 3.3% to $0.43 on Friday, after three successive sessions in a row of losses. NASDAQ jumped 0.95% to $13,630.61, following the last session’s upward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, SmileDirectClub has a trailing twelve months EPS of $-2.628.

Yearly Top and Bottom Value

SmileDirectClub’s stock is valued at $0.43 at 08:34 EST, way under its 52-week high of $2.26 and way higher than its 52-week low of $0.32.

More news about SmileDirectClub.

2. Royal Caribbean Cruises (RCL) – Premarket: -0.81%

Royal Caribbean Cruises Ltd. operates as a cruise company worldwide. The company operates cruises under the Royal Caribbean International, Celebrity Cruises, and Silversea Cruises brands, which comprise a range of itineraries. As of February 13, 2023, it operated 64 ships. The company was founded in 1968 and is headquartered in Miami, Florida.

NYSE ended the session with Royal Caribbean Cruises rising 0.06% to $97.41 on Friday while NYSE dropped 0.36% to $15,600.70.

Earnings Per Share

As for profitability, Royal Caribbean Cruises has a trailing twelve months EPS of $-4.12.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -29.56%.

Volume

Today’s last reported volume for Royal Caribbean Cruises is 981344 which is 72.76% below its average volume of 3603440.

Previous days news about Royal Caribbean Cruises

• Royal caribbean cruises (nyse: rcl) sets sail for profitable growth. According to FXStreet on Wednesday, 21 June, "As the world emerges from the pandemic and travel restrictions gradually ease, Royal Caribbean Cruises is well-positioned to capitalize on the pent-up demand for travel and the resurging interest in cruise vacations.", "Since the 2020 market crash, Royal Caribbean Cruises Ltd (NYSE: RCL) has demonstrated a remarkable recovery, embarking on a strong bullish journey. "

More news about Royal Caribbean Cruises.

3. AMC (AMC) – Premarket: -0.72%

AMC Entertainment Holdings, Inc., through its subsidiaries, engages in the theatrical exhibition business. The company owns, operates, or has interests in theatres in the United States and Europe. AMC Entertainment Holdings, Inc. was founded in 1920 and is headquartered in Leawood, Kansas.

NYSE ended the session with AMC sliding 7.95% to $4.17 on Friday, after five successive sessions in a row of losses. NYSE fell 0.36% to $15,600.70, following the last session’s downward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, AMC has a trailing twelve months EPS of $-0.76.

More news about AMC.

4. Inovio Pharmaceuticals (INO) – Premarket: -0.07%

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia, including cervical, vulvar, and anal dysplasia and is under phase II/III clinical trials; INO-3107 for HPV-related recurrent respiratory rapillomatosis and is under Phase 1/2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under phase 1b trial; and INO-4500 vaccine for lassa fever, which is under phase 1b trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

NASDAQ ended the session with Inovio Pharmaceuticals dropping 5.59% to $0.45 on Friday, after two consecutive sessions in a row of losses. NASDAQ jumped 0.95% to $13,630.61, following the last session’s upward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Inovio Pharmaceuticals has a trailing twelve months EPS of $-0.94.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -87.1%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Inovio Pharmaceuticals’s stock is considered to be overbought (>=80).

Volatility

Inovio Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.85%, a negative 1.93%, and a positive 4.37%.

Inovio Pharmaceuticals’s highest amplitude of average volatility was 4.21% (last week), 3.53% (last month), and 4.37% (last quarter).

Yearly Top and Bottom Value

Inovio Pharmaceuticals’s stock is valued at $0.45 at 08:34 EST, below its 52-week low of $0.47.

More news about Inovio Pharmaceuticals.

5. Aware, Inc. (AWRE) – Premarket: 0%

Aware, Inc., a authentication company, provides biometrics software products and solutions for government agencies and commercial entities in the United States, Brazil, the United Kingdom, and internationally. The company offers biometric software solution, which includes Knomi, a mobile biometric framework which provides multiple biometric modality options; AwareABIS, an automated biometric identification system used for large-scale biometric identification and deduplication; AFIX suite used for small-scale law enforcement focused biometric identification; and AFIX Tracker for fingerprint, palmprint, and latent print identification. It also provides BioSP, a service-oriented platform enables biometric system with advanced biometric data processing and management in a web services architecture; WebEnroll, a browser-based biometric enrollment and data management solution; and AwareID, an adaptive authentication platform provides biometric face and voice analysis, and document validation for cloud-based biometric application programming interfaces and turnkey services. In addition, the company offers biometrics applications, such as Nexa line, a biometric search and match SDKs including Nexa Fingerprint, Nexa Face, Nexa Iris, and Nexa Voice; and AwareXM, an interoperable fingerprint matching SDK that provides fingerprint minutiae extraction, template generation, and fingerprint authentication. Further, it sells imaging products used in medical and advanced imaging application; offers program management and software engineering services, and software maintenance services. The company sells its products, services, and solutions through systems integrators, direct, and original equipment manufacturers and value added resellers channel Aware, Inc. was incorporated in 1986 and is headquartered in Burlington, Massachusetts.

NASDAQ ended the session with Aware, Inc. dropping 1.2% to $1.65 on Friday, following the last session’s downward trend. NASDAQ jumped 0.95% to $13,630.61, following the last session’s upward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Aware, Inc. has a trailing twelve months EPS of $-0.09.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.07%.

Volatility

Aware, Inc.’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.22%, a positive 0.16%, and a positive 2.04%.

Aware, Inc.’s highest amplitude of average volatility was 2.86% (last week), 2.29% (last month), and 2.04% (last quarter).

Sales Growth

Aware, Inc.’s sales growth is negative 3.3% for the current quarter and 52.6% for the next.

More news about Aware, Inc..

6. Fox Corporation (FOX) – Premarket: 0%

Fox Corporation operates as a news, sports, and entertainment company in the United States (U.S.). The company operates through Cable Network Programming; Television; and Other, Corporate and Eliminations segments. The Cable Network Programming segment produces and licenses news, business news, and sports content for distribution through traditional and virtual multi-channel video programming distributors (MVPDs) and other digital platforms, primarily in the U.S. It operates FOX News, a national cable news channel; FOX Business, a business news national cable channel; FS1 and FS2 multi-sport national networks; FOX Sports Racing, a video programming service that comprises motor sports programming; FOX Soccer Plus, a video programming network for live soccer and rugby competitions; FOX Deportes, a Spanish-language sports programming service; and Big Ten Network, a national video programming service. The Television segment acquires, produces, markets, and distributes programming. It operates The FOX Network, a national television broadcast network that broadcasts sports programming and entertainment; Tubi, an advertising-supported video-on-demand service; Fox Alternative Entertainment, a full-service production studio that develops and produces unscripted and alternative programming; MyNetworkTV, a programming distribution service; and Blockchain Creative Labs, which is focuses on the creation, distribution and monetization of Web3 content. This segment owns and operates 29 broadcast television stations. The Other, Corporate and Eliminations segment owns the FOX Studios Lot that provides production and post-production services, including 15 sound stages, two broadcast studios, theaters and screening rooms, editing rooms, and other television and film production facilities in Los Angeles, California. The company was incorporated in 2018 and is based in New York, New York.

NASDAQ ended the session with Fox Corporation dropping 0.68% to $30.82 on Friday while NASDAQ rose 0.95% to $13,630.61.

Earnings Per Share

As for profitability, Fox Corporation has a trailing twelve months EPS of $2.14.

PE Ratio

Fox Corporation has a trailing twelve months price to earnings ratio of 14.4. Meaning, the purchaser of the share is investing $14.4 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.91%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Fox Corporation’s EBITDA is 1.38.

Sales Growth

Fox Corporation’s sales growth is 5.7% for the present quarter and 5.5% for the next.

More news about Fox Corporation.

7. Fox Corporation (FOXA) – Premarket: 0%

Fox Corporation operates as a news, sports, and entertainment company in the United States (U.S.). The company operates through Cable Network Programming; Television; and Other, Corporate and Eliminations segments. The Cable Network Programming segment produces and licenses news, business news, and sports content for distribution through traditional and virtual multi-channel video programming distributors (MVPDs) and other digital platforms, primarily in the U.S. It operates FOX News, a national cable news channel; FOX Business, a business news national cable channel; FS1 and FS2 multi-sport national networks; FOX Sports Racing, a video programming service that comprises motor sports programming; FOX Soccer Plus, a video programming network for live soccer and rugby competitions; FOX Deportes, a Spanish-language sports programming service; and Big Ten Network, a national video programming service. The Television segment acquires, produces, markets, and distributes programming. It operates The FOX Network, a national television broadcast network that broadcasts sports programming and entertainment; Tubi, an advertising-supported video-on-demand service; Fox Alternative Entertainment, a full-service production studio that develops and produces unscripted and alternative programming; MyNetworkTV, a programming distribution service; and Blockchain Creative Labs, which is focuses on the creation, distribution and monetization of Web3 content. This segment owns and operates 29 broadcast television stations. The Other, Corporate and Eliminations segment owns the FOX Studios Lot that provides production and post-production services, including 15 sound stages, two broadcast studios, theaters and screening rooms, editing rooms, and other television and film production facilities in Los Angeles, California. The company was incorporated in 2018 and is based in New York, New York.

NASDAQ ended the session with Fox Corporation falling 0.87% to $32.90 on Friday, after four consecutive sessions in a row of losses. NASDAQ rose 0.95% to $13,630.61, following the last session’s upward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, Fox Corporation has a trailing twelve months EPS of $2.14.

PE Ratio

Fox Corporation has a trailing twelve months price to earnings ratio of 15.37. Meaning, the purchaser of the share is investing $15.37 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.91%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 4.1% and a negative 7.4%, respectively.

Yearly Top and Bottom Value

Fox Corporation’s stock is valued at $32.90 at 08:34 EST, way under its 52-week high of $37.26 and way higher than its 52-week low of $28.01.

Revenue Growth

Year-on-year quarterly revenue growth grew by 18.2%, now sitting on 14.91B for the twelve trailing months.

More news about Fox Corporation.

8. Merrimack Pharmaceuticals (MACK) – Premarket: 0%

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

NASDAQ ended the session with Merrimack Pharmaceuticals rising 0.32% to $12.40 on Friday, following the last session’s upward trend. NASDAQ rose 0.95% to $13,630.61, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Merrimack Pharmaceuticals has a trailing twelve months EPS of $-0.12.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.12%.

Moving Average

Merrimack Pharmaceuticals’s worth is below its 50-day moving average of $12.56 and way higher than its 200-day moving average of $10.01.

Volatility

Merrimack Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.16%, a negative 0.02%, and a positive 0.83%.

Merrimack Pharmaceuticals’s highest amplitude of average volatility was 0.38% (last week), 0.42% (last month), and 0.83% (last quarter).

Yearly Top and Bottom Value

Merrimack Pharmaceuticals’s stock is valued at $12.40 at 08:34 EST, below its 52-week high of $13.66 and way above its 52-week low of $3.00.

More news about Merrimack Pharmaceuticals.

9. iShares Short-Term (IGSB) – Premarket: 0.08%

NASDAQ ended the session with iShares Short-Term dropping 0.11% to $50.10 on Friday while NASDAQ rose 0.95% to $13,630.61.

Earnings Per Share

As for profitability, iShares Short-Term has a trailing twelve months EPS of $2.48.

Volume

Today’s last reported volume for iShares Short-Term is 543705 which is 86.21% below its average volume of 3944390.

More news about iShares Short-Term.

10. GoPro (GPRO) – Premarket: 0.47%

GoPro, Inc. develops and sells cameras, mountable and wearable accessories, and subscription services and software in the Americas, Europe, the Middle East, Africa, the Asia and Pacific region, and internationally. The company provides cloud connected HERO11 Black, HERO11 Black Mini, HERO10 Black, HERO10 Black Bones, HERO9 Black, and HERO8 Black waterproof cameras; MAX, a 360-degree waterproof camera; GoPro, a subscription service that includes full access to the Quik app, cloud storage supporting source video and photo quality, camera replacement, and damage protection; Quik subscription offers access to editing tools, which allows users to edit photos, videos, and create cinematic stories; and Quik app, a mobile app that enable users to get their favorite photos and videos with footage from any phone or camera. It also offers mounts and accessories comprising equipment-based mounts consisting of helmet, handlebar, roll bar, and tripod mounts that enable consumers to wear the mount on their bodies, such as wrist housings, magnetic swivel clips, chest harnesses, and head straps; media, display, and light mods; spare batteries, dive filters, and charging accessories and cables; and lifestyle gears. In addition, the company provides mobile and web applications that provides media workflow for archiving, editing, multi-clip story creation, and sharing content on the fly. GoPro, Inc. markets and sells its products through retailers and wholesale distributors, as well as through its GoPro.com website. The company was formerly known as Woodman Labs, Inc. and changed its name to GoPro, Inc. in February 2014. GoPro, Inc. was founded in 2002 and is headquartered in San Mateo, California.

NASDAQ ended the session with GoPro dropping 1.67% to $4.12 on Friday while NASDAQ rose 0.95% to $13,630.61.

Earnings Per Share

As for profitability, GoPro has a trailing twelve months EPS of $-0.05.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.14%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 19.4%, now sitting on 1.05B for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 162.5% and a negative 21.1%, respectively.

More news about GoPro.

Stay up to date with our premarket winners and losers daily report